Is the recommendation not to use rifampin plus pyrazinamide for latent tuberculosis treatment always imperative?

Chest. 2004 Aug;126(2):657-8. doi: 10.1378/chest.126.2.657.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibiotics, Antitubercular / administration & dosage*
  • Antitubercular Agents / administration & dosage*
  • Drug Resistance, Multiple, Bacterial
  • Drug Therapy, Combination
  • Humans
  • Pyrazinamide / administration & dosage*
  • Rifampin / administration & dosage*
  • Tuberculosis / drug therapy*

Substances

  • Antibiotics, Antitubercular
  • Antitubercular Agents
  • Pyrazinamide
  • Rifampin